$47.5 Million in New Financing Secured from Existing Noteholders, Upsized from Initial $40 million Commitment Supports Mission to Continue Serving Life Sciences Researchers Worldwide SEATTLE —NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its existing […]
Zetta Genomics has expanded its second seed round, attracting new investment and growth expertise. With £6.2 million secured over two years, Zetta scales global operations and customer offerings to transform precision medicine and personalised healthcare. Fast-scaling genomic data pioneer, Zetta Genomics, has expanded its second seed round – securing an additional £1.8 million and strengthening investor expertise. […]
Initiates Voluntary Chapter 11 Restructuring Proceedings with Additional $40 Million in Financing Secured from Existing Noteholders to Facilitate Process Continuing to Serve Life Sciences Researchers Worldwide SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that steps are being […]
LONDON — Biomarker pioneer Inoviv has secured significant funding from venture capital firm Hoxton Ventures and leading investment manager Foresight Group to expand the delivery of highly accurate, fully quantitative targeted biomarker workflows and panels. Building on previous funding from Hoxton Ventures, this latest investment will enable Inoviv to further expand its commercial activities to […]
Funding will accelerate commercialization of the Singulator platform which enables single cell or nuclei suspensions from solid tissues LIVERMORE, Calif. — S2 Genomics, the leading manufacturer of tissue sample preparation systems for single cell genomics assays, announced today that it has raised $16 million in Series A funding from BroadOak Capital Partners and Research Corporation […]
CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round. The company aims to enable the cost-effective, reliable, and rapid development of new cell therapies. Stem cells unlock a range of treatment possibilities that have not previously been available to […]
SEATTLE — Pluristyx, a leading provider of tools, technologies and services for the development of cell therapies, has today announced the closing of a major fundraising round led by BroadOak Capital Partners. The oversubscribed funding round also featured participation from existing investors and key opinion leaders across the life sciences industry. This infusion of capital […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy to further strengthen growth opportunities for both organizations. “We believe having the cell analysis team as part of DGG is a natural fit given […]
MicrofluidX secures £1m funding via Innovate UK Investor Partnerships Future Economy programme, supported by Longwall Ventures. Stevenage, UK– MicrofluidX (MFX), a UK-based developer of technologies that streamline the development and deployment of cell and gene therapies, is delighted to announce that it has been awarded £685,000 in funding from Innovate UK via their Investor Partnership […]
Funding will drive expansion of company’s product portfolio and commercial reach. SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has closed a total of $50 million in financing from a Series C equity raise and the closing of a debt facility. Soleus Capital led the Series […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
